Delivery Order SPE2DB24D1205-SPE2DB25FCSXP

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $71,774.93 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the supply of LATUDA 80 MG TABLETS 30S, a prescription medication, to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Latuda 40 mg tablet 30s. The $5,592.70 firm fixed-price delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Latuda 40 mg tablets. The $19,603.20 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the company's parent organization, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order, with a Firm Fixed Price pricing type, valued at $1,195.04. The contract is for the supply of the prescription drug Latuda 40 mg tablets. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,278.60 firm fixed-price delivery order is for the supply of Latuda 80 mg tablets, a medication used to treat psychiatric conditions. The contract has an ultimate completion date of October 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,145.74 firm fixed-price delivery order is for the supply of the antipsychotic medication Latuda 20 mg tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Latuda 20 mg tablets. The contract has a ceiling value of $2,125.48 and runs through December 2024. It is a firm fixed-price delivery order contract with no set-aside requirements, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), has established...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a $3,511.11 Delivery Order for the supply of Latuda 40 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.97 firm fixed-price delivery order is for the supply of Latuda 40 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,173.87, is a delivery order for the supply of the antipsychotic medication Latuda 20 mg tablets. The contract has a firm fixed price and an ultimate completion date of January 13, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSXP
    Delivery Order

This federal contract award, valued at $23,755.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LATUDA 40 MG TABLET 30S, a prescription medication, to support military healthcare programs.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal agencies. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs. These contracting mechanisms enable the efficient procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/9/25, 9:45 AM